| Jul 18, 2014
| 8:20 AM
AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning.
The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
| Jul 17, 2014
| 6:55 AM
AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes.
The deal will allow North Chicago-based pharmaceutical...
| Jul 18, 2014
| 4:51 PM
A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings.
Illinois drug maker AbbVie Inc. said Friday that it...
| Jul 19, 2014
AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom.
The deal, announced by both companies in a...
| Jul 22, 2014
Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival.
Stung by criticism that it'...
| Jul 9, 2014
| 6:59 AM
AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his company's takeover bid for Shire Plc.
The North Chicago-based pharmaceutical...
| Jul 11, 2014
| 2:06 PM
Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases.
Shire, in a release, said it would provide a further update "when appropriate." It...
| Jul 14, 2014
| 7:49 AM
Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion.
The deal, which will give Abbott a roughly...
| Jul 16, 2014
| 11:49 AM
AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way...
| Jun 23, 2014
| 11:53 AM
Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm.
Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
| Jun 23, 2014
| 1:30 PM
Abbott Laboratories said Monday it has agreed to acquire a Russian pharmaceutical manufacturer for between $395 million and $495 million in cash plus the assumption of about $136 million in debt. The Lake County-based medical products company will...